Investor Overview
Corporate Profile
Affymax, Inc. is a biopharmaceutical company committed to developing novel drugs to improve the treatment of serious and often life-threatening conditions. Affymax’s product candidate, Hematide™, has been investigated in Phase 3 clinical trials for the treatment of anemia associated with chronic renal failure.
Webcasts
|
Feb 9, 2010
|
Recent Press Releases
Transfer Agent
Computershare Trust Company, Inc.
350 Indiana Street, Suite 800, Golden, Colorado 80401
(800) 962-4284